Skip to main navigation
About Us
About Us
Leadership
Board of Directors
Patient Community
Focus Areas
Focus Areas
KMT2Ar Acute Leukemias
NPM1m Acute Myeloid Leukemia
Chronic Graft-Versus-Host Disease
Pipeline
Pipeline
Menin Inhibitor
Anti-CSF-1R Monoclonal Antibody
Entinostat
Publications & Meeting Presentations
Our Products
Patients
Patients
Managed Access Programs
Investors
Careers
News
Contact Us
Event Details
Investors
Home
Press Releases
Events & Presentations
Corporate Governance
Governance Overview
Management
Board of Directors
Committee Composition
Contact the Board
Financial Information
Financial Overview
SEC Filings
Annual Reports and Proxies
Quarterly Results
Key Ratios
Stock Information
Stock Quote & Chart
Historic Stock Lookup
Analyst Coverage
Analyst Consensus
Shareholder Services
Investor FAQs
RSS Feeds
Email Alerts
Citi’s 2025 BioPharma Back to School Conference
09.02.25 /
4:45 PM EDT
Listen to webcast